富血小板血浆纤维蛋白胶治疗腔肺连接术后乳糜胸
本研究报道了2010至2019年间27例腔肺连接术后持续性乳糜胸患儿,在初期保守治疗无效后接受同种异体富血小板血浆纤维蛋白胶(PRP-FG)治疗。随访9年,治疗成功者均健康存活且无进一步并发症。
要点
- PRP-FG可作为腔肺连接术后持续性乳糜胸再手术前的保守治疗选择。
- 2例无反应者再手术后死亡,成功治疗者随访无进一步并发症。
核心结论
- 儿科心脏手术后顽固性持续性乳糜胸对PRP-FG治疗有积极反应。
- 该技术避免了再次手术,并显著降低了发病率和死亡率。
研究设计与样本
- 回顾性报道2010至2019年共9年间27例腔肺连接术后持续性乳糜胸患者。
- 患者平均潜伏期11天(范围10-15天),均对初期保守治疗方案无积极反应。
- 患者接受同种异体PRP-FG治疗并随访9年。
主要发现
- 2例患者对治疗无反应,再手术后死亡。
- 所有成功治疗的患者在随访中继续健康生活,无进一步并发症。
临床怎么用
- 对于腔肺连接术后持续性乳糜胸且初期保守治疗无效的患儿,可考虑在再手术前应用PRP-FG作为保守治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The postoperative persistence of chylothorax is a fatal complication of paediatric cardiac surgery. There is an urgent need for an effective treatment of chylothorax. This study reports the application of allogenic platelet-rich plasma fibrin glue (PRP-FG) as a conservative therapy before reoperation. METHODS: Over a 9-year period, from 2010 to 2019, 27 patients with persistent chylothorax following a cavopulmonary connection, with a mean latency period of 11 days (range 10-15 days), were treated with PRP-FG. These patients were selected because they had not responded positively to initial conservative management plans. The patients were followed up for 9 years. RESULTS: Twenty-five patients (92%) responded positively to treatment with PRP-FG; 2 patients did not respond to the treatment and died after reoperation. All of the successfully treated patients in follow-up continued to live a healthy life without further complications. CONCLUSIONS: Recalcitrant chylothorax that persists after paediatric cardiac surgery responded positively to treatment with PRP-FG. This technique precluded the need for another operation and significantly decreased the morbidity and mortality rates.
引用
- Tashnizi MA, Maleki MH, Javedanfar O, et al. Platelet-rich plasma fibrin glue for treatment of chylothorax following cavopulmonary connections. Eur J Cardiothorac Surg. 2020. PMID: 32808042. doi:10.1093/ejcts/ezaa243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。